AzTrials
AzTrials

HaemodialysisPhase 1/2NCT00829153

U Clip Study - Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis

A Phase 1/2 study testing U Clip and Conventional prolene anastomosis in people with Haemodialysis, run by Royal Hobart Hospital at 1 site in Australia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The requirements for haemodialysis are increasing. There is now acceptance that the most durable AV fistulae are those created from the patients own veins. Use of the radiocephalic arteriovenous fistula as an autologous vascular access dates back to the 1960's. (Brescia MJ, Cimino JE. Appel K, Hurwich BJ. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Haemodialysis
What is being tested?
U Clip and Conventional prolene anastomosis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteAustralia
Study dates
Jan 2007to Aug 2010
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Requirement for AV fistula creation for haemodialysis
  • Pre operative upper limb venous and arterial duplex scan showing intended arterial lumen diameter of 2mm or more and vein diameter of 3mm or more.

Who cannot join

  • Use of prosthetic graft for fistula creation.
  • Donor arterial lumen diameter less then 2mm
  • Recipient venous diameter less than 3mm.
  • Proximal venous thrombosis.

Trial locations and contacts

1 site in 1 country.

Stuart R walker, MBBS contact

03 6227064

stuart.walker@dhhs.tas.gov.au

Australia1 site, 1 recruiting
  • Launceston general Hospital

    Launceston

    Stuart R walker, MBBS, stuart.walker@dhhs.tas.gov.au

    Stuart R Walker, MBBS

    Recruiting

Other trials in Australia

About this study

Official title: A Pilot, Randomised, Blinded Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis for Creating of Autologous Arteriovenous Fistulae

The requirements for haemodialysis are increasing. There is now acceptance that the most durable AV fistulae are those created from the patients own veins. Use of the radiocephalic arteriovenous fistula as an autologous vascular access dates back to the 1960's. (Brescia MJ, Cimino JE. Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966; 275: 1089 - 1092.) Once established, it has good long term survival and a low complication rate. However, the success rate at creation of a useable AV fistula are not good. In a meta-analysis published in 2005, the primary failure rate of a radiocephalic fistula was 15.3% and the primary and secondary patency rates were 62.5% and 66.0% at one year. (Rooijens PPGM, Tordoir JHM, Stijnen T, Burgmans JPJ, Smet AAEA and Yo TI. Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg 2004; 28, 583-589). Reasons for this are multiple but it appears as though the main determinants are the quality of the patients veins and the technical skill of the surgeon. Low patency rates are also seen in females and those with small veins and arteries. Creating an anastomosis between a small vein and artery is technically challenging. This is traditionally preformed with a continuous prolene suture. Recently, Medtronic have been marketing the U Clip Anastomotic Device. This is a self closing devise which could be called a vascular clip. Reported advantages of this clip include better patency rates and faster operations. However, to our knowledge there is no randomised evidence to support this with regards to AV fistulas.

The vascular anastomosis originally developed by Alexis Carrel used interrupted sutures. Over time this was replaced by a continuous suture technique which was felt to be quicker and had similar patency rates. However, microvascular, paediatric and neurovascular surgeons have shown that there are advantages to an interrupted technique. (Hattori H, Killen DA, Green JW. Influence of suture material and technic on patency of anastomosed arteries of less than 1.5mm. Am Surg. 1970; 36: 352 - 354. Cobbett JR. Microvascular surgery. Surg Clin N Am. 1962; 47: 521.). The reasons for the improved patency with interrupted anastomoses are firstly increased anastomotic compliance and flow rate and secondly elimination of the pursestring effect and puckering seen with continuous sutures.

Read more

In a prospective but non randomised study to compare interrupted U clips with historical published results, the patency rate of coronary anastomoses was 100% at 6 months using the U clips compare to a patency rate of 90 -100% in the published series. (Wolf RK, Alderman EL, Caskey MP et al. Clinical and six month angiographic evaluation of coronary arterial graft interrupted anastomoses by use of a self closing clip device: a multicentre prospective clinical trial. J Thorac cardiovasc Surg 2003; 126(1): 168 - 178.)

Reports from single centres have concluded that the U Clips offer the opportunity to create superior interrupted anastomoses for AV fistula, even in patients who would otherwise be considered poor candidates for fistula creation. (Ross JR. Creation of native arteriovenous fistulas with interrupted anastomoses using a self closing clip device - one clinics experience. Journal of vascular Access 2002; 3: 140 - 146). In this report with small numbers, the radiocephalic fistulas had an 8 week maturation rate of 93%. Of the 28 patients having a radiocephalic fistula, 10 had veins of between 1.0 - 1,5mm diameter.

The aim of this pilot study will be to assess if there is a clinical difference in the maturation rates of autologous AV fistulae when a clipped anastomosis is compared to a conventional prolene anastomosis.

Read the detailed description

Method. A prospective, randomised, blinded study to compare continuous prolene anastomosis with interrupted U clip anastomosis in creation of autologous AV fistula.

Recruitement. Patients will be referred by the nephrologists to the vascular surgeons for assessment prior to creation of an AV fistula in the usual way. Current unit guidelines are that all patients have a pre operative duplex scan to assess the superficial veins. If the patient meets the entry criteria and there are no exclusion criteria, the patient will be consented to be involved in the trial.

The patient will be admitted for surgery and anaethetised in the usual way. Once the vein and artery have been dissected and prepared for anastomosis a sealed envelop will be opened. This will instruct the surgeon to perform the anastomosis with either a conventional continuous prolene suture or interrupted U Clips. The envelop will also contain a study number which is recorded on the operation note. The operation not must no include the words prolene anastomoiss or clipped anastomosis. In this way subsequent assessment by nephrologists will be blinded.

Patients will then undergo follow up in the usual way by their nephrologists. The nephrologist should then report the subsequent outcome of the fistula and patients will undergo clinical follow up alone.

Randomisation. This will be performed using an electronic random number generator. This will result in a study number and surgeon instruction being placed in an opaque sealed envelop which will only be opened in theatre just before the anastomosis is performed. It will be a 1:1 randomisation.

Primary outcome measure. A functioning fistula which is used for haemodialysis on three or more occasions.

Secondary outcome measures.

  1. Fistula patency as assessed clinically.
  2. Need for fistula intervention in order to maintain patency.
Conditions
Haemodialysis
Being tested
U Clip, Conventional prolene anastomosis
Keywords
Fistula patency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • U ClipDevice

    Interuppted nitional clips

  • Conventional prolene anastomosisProcedure or surgery

    Continuous prolene anastomosis

Study groups in NCT00829153
Study groupRoleWhat they receive
U clipExperimentalAnastomosis with U clips
Receives: Device: U Clip
2Active comparatorProlene anastomosis
Receives: Procedure: Conventional prolene anastomosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. A functioning fistula which is used for haemodialysis on three or more occasions.

    Measured: Until commencement of dialysis with the fistula

Secondary outcomes (2)
  1. Fistula patency as assessed clinically.

    Measured: For the life of the fistula

  2. Need for fistula intervention in order to maintain patency.

    Measured: For the life of the fistula

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2009 (estimated)
  2. Study startJan 2007
  3. Primary completionAug 2010 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00829153
Sponsor's protocol ID
H8974
Status last verified
Mar 2010
First submitted
22 Jan 2009
Last updated
16 Mar 2010
Results posted
No
Data monitoring committee
No

Publications

  • Walker SR. U Clips for arteriovenous anastomosis: a pilot, randomized study. ANZ J Surg. 2012 Sep;82(9):630-2. doi: 10.1111/j.1445-2197.2012.06153.x. Epub 2012 Aug 20.

    PubMed 22900497

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing U Clip and Conventional prolene anastomosis in people with Haemodialysis, run by Royal Hobart Hospital at 1 site in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Mar 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Stuart R walker, MBBS (03 6227064, stuart.walker@dhhs.tas.gov.au), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

A functioning fistula which is used for haemodialysis on three or more occasions. (time frame: Until commencement of dialysis with the fistula). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00829153, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2010.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in